Giuseppe Buono /LinkedIn
May 15, 2025, 01:53
Giuseppe Buono: Join us for the poster session at the ESMOBC25
Giuseppe Buono, Medical Doctor at IRCCS National Cancer Institute G. Pascale Foundation, Naples, shared a post on LinkedIn:
“Join us at 12.00 for the poster session at the ESMOBC25!
Our amazing research group from the Department of Breast Oncology at IRCCS Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy, lead by prof. Michelino De Laurentiis is going to present a lot of interesting data:
Poster 354P– Sacituzumab Govitecan for the treatment of metastatic triple-negative breast cancer patients: a multicenter real-world updates analysis Roberta Caputo
Poster 223P – Pathologic Complete Response (pCR) as a Surrogate Endpoint for Long-Term Survival in Early Triple-Negative Breast Cancer (eTNBC) Treated with Neoadjuvant Immune Checkpoint Inhibitors (ICIs): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs) Michela Piezzo
Poster 373P – Investigating the association between CDK4/6 inhibitor clinical outcomes and breast cancer histotype Claudia von Arx
Poster 286P – Assessment of non genetic factors with breast cancer risk in women BRCA carriers Alessandra Calabrese
Poster 209P – Comparative Analysis Of Clinician And AI Decision-Making In HR+/HER2- Early Breast Cancer Within Routine Clinical Practice And Clinical Trial RossanaDiRienzo
Poster 371P – Palbociclib Plus Endocrine Therapy in Clinically Relevant HR+/HER2- mBC Subgroups: A Real-World Multicenter Study Roberto Buonaiuto
Finally, I Will present:
Poster 486P – Social costs and Quality of life in breast cancer patients enrolled in GIM30-RAPID: a prospective, observational, multicenter study evaluating the safety of ReAl-life Pertuzumab (P) and Trastuzumab (T) Fixed Dose combination (FDC)Take also a look to:
Poster 315P– Real-World Safety and Effectiveness of T-DXd in older Breast cancer patients: updated analysis in an expanded cohort from the TREX-Old Registry presented by my friend Antoine Deleuze were I am the last author.”
More posts featuring Giuseppe Buono.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 19, 2025, 01:43
May 18, 2025, 13:40
May 18, 2025, 13:31
May 18, 2025, 12:54